Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage

Abstract

Restarting warfarin therapy in patients with a recent WAICH is associated with a low risk of recurrence, but patients are subjected to known, substantial risks of warfarin use. Withholding warfarin therapy is associated with a risk of thromboembolization.